Flerie AB (publ) (STO:FLERIE)
Sweden · Delayed Price · Currency is SEK 21.00
+0.30 (1.45%)
Jul 24, 2026, 3:58 PM CET
Flerie AB Market Cap
Flerie AB has a market cap or net worth of 1.79 billion as of July 24, 2026. Its market cap has decreased by -45.16% in one year.
Market Cap
1.79B
Enterprise Value
1.49B
Revenue
-5.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.00
ChartMarket Cap Chart
Since June 11, 2024, Flerie AB's market cap has decreased from 4.11B to 1.79B, a decrease of -56.30%. That is a compound annual growth rate of -32.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 1.79B | -38.13% |
| Dec 30, 2025 | 2.90B | -20.86% |
| Dec 30, 2024 | 3.67B | -10.74% |
| Jun 11, 2024 | 4.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.40B |
| Vicore Pharma Holding AB | 3.23B |
| Egetis Therapeutics AB | 2.95B |
| Saniona AB | 1.80B |
| BioInvent International AB | 1.51B |
| Genovis AB (publ.) | 1.27B |
| Medivir AB | 1.08B |
| SynAct Pharma AB | 1.03B |